Antimetabolites: all 7,305 studies that test it
Page 39 of 74. Open to participants first (1,098), then studies with results posted, then the rest; newest registration first within each.
- Hydroxyurea Optimization Through Precision StudyCompletedNCT03789591Phase 3
- A Randomized Phase III Study Comparing POF With SOX/CAPOX/FOLFOX as a Postoperative Adjuvant Chemotherapy for Curatively Resected Stage III Gastric CancerStatus unknownNCT03788226Phase 3
- Apatinib Combined With POF for Second-line Treatment of Gastric AdenocarcinomaStatus unknownNCT03788174Phase 2
- A Study to Evaluate MIV-818 in Patients With Liver Cancer ManifestationsCompletedNCT03781934Phase 1/2
- AIH for Spinal Cord RepairTerminatedNCT03780829Early Phase 1
- Adjuvant Chemotherapy for Biliary Tract Cancer After Curative ResectionStatus unknownNCT03779035Phase 3
- FOLFIRINOX for 2nd-line Treatment of BTCCompletedNCT03778593Phase 2
- Study of Anlotinib Combined With Pemetrexed in Patients With Advanced Nonsquamous NSCLCStatus unknownNCT03778138Phase 2
- Evaluation of a Treatment With Allopurinol in Adenylosuccinate Lyase DeficiencyCompletedNCT03776656Phase 2
- Methotrexate and Prednisolone Study in Erythema Nodosum LeprosumActive, not recruitingNCT03775460Not applicable
- Cyclophosphamide and Azathioprine vs Tacrolimus in Antisynthetase Syndrome-related Interstitial Lung DiseaseStatus unknownNCT03770663Phase 3
- Maintenance Therapy for Small-cell Lung CancerCompletedNCT03769935Phase 2
- MRD-guided Treatment in NPM1mut AML PatientsTerminatedNCT03769532Phase 2
- A Study in Patients Previously Enrolled in a Genentech and/or F. Hoffmann-La Roche Ltd Sponsored Atezolizumab StudyActive, not recruitingNCT03768063Phase 3
- Anlotinib Plus Pemetrexed or Pemetrexed for Previously Untreated Elderly (>=70) or PS=2 Non-squamous NSCLCStatus unknownNCT03768037Phase 4
- Effect of Allopurinol or Febuxostat to Prevent Contrast Induced Acute Kidney Injury (CI-AKI)Status unknownNCT03767322Phase 2
- Liposomal iRInotecan, Carboplatin or oXaliplatin for Esophagogastric CancerActive, not recruitingNCT03764553Phase 2
- A Phase II Study of Lonsurf (TAS-102) in Metastatic Platinum and Checkpoint Inhibitor-resistant Bladder CancerStatus unknownNCT03762161Phase 2
- Efficacy and Safety of Atezolizumab Plus Capecitabine Adjuvant Therapy for Triple Receptor-Negative Breast CancerActive, not recruitingNCT03756298Phase 2
- Pemetrexed and Avelumab in Treating Patients With MTAP-Deficient Metastatic Urothelial CancerActive, not recruitingNCT03744793Phase 2
- Prexasertib in Combination With MEC in Relapsed/Refractory AML and High Risk MDS - a Phase I TrialTerminatedNCT03735446Phase 1
- Short Course Radiation Therapy Followed by Pre-operative Chemotherapy and Surgery in High-risk Rectal CancerStatus unknownNCT03729687Phase 2
- Bioequivalence Study to Compare Sol-Gel Technologies' 5-FU Cream With Efudex® (5-FU) CreamCompletedNCT03727074Phase 3
- Phase Ⅱ Study of HAIC of FOLFOX vs. Sorafenib in HCC Refractory to TACEWithdrawnNCT03722498Phase 2
- Azacitidine and Rituximab-GDP Immunochemotherapy in Patients With Relapsed/Refractory Diffuse Large B-Cell LymphomaStatus unknownNCT03719989Phase 2
- Early Systemic Central Nervous System Prophylaxis in Diffuse Large B-cell LymphomaWithdrawnNCT03719560Phase 2
- Clinical Study of CAR-BCMA T in Patients With Refractory or Relapsed Multiple MyelomaStatus unknownNCT03716856Phase 1
- Leflunomide Treatment for IgG4-RDStatus unknownNCT03715699Not applicable
- CS1-CAR T Therapy Following Chemotherapy in Treating Patients With Relapsed or Refractory CS1 Positive Multiple MyelomaSuspendedNCT03710421Phase 1
- Enzalutamide and Decitabine in Treating Patients With Metastatic Castration Resistant Prostate CancerWithdrawnNCT03709550Phase 1/2
- Leflunomide in Previously Treated Metastatic Triple Negative CancersCompletedNCT03709446Phase 1/2
- Bevacizumab Plus Capecitabin vs S-1 as Maintenance Treatment Following First-line Chemotherapy in the Patients With Advanced Colorectal AdenocarcinomaWithdrawnNCT03708536Phase 3
- Study of the Combination of Apatinib and POFStatus unknownNCT03707639Phase 2
- Rh-Endostatin (Endostar®) Continuous Intravenous InfusionStatus unknownNCT03706703Phase 2
- Gemcitabine & Nab-Paclitaxel in Pancreatic Adenocarcinoma With Positive Peritoneal CytologyStatus unknownNCT03703089Phase 1
- Alternative Neoadjuvant Chemotherapy in Resectable and Borderline Resectable Pancreatic CancerStatus unknownNCT03703063Phase 1
- Safety and Clinical Activity Study of Combination Azacitidine and Avelumab in Patients With Acute Myeloid Leukemia (AML) and Minimal Residual Disease (MRD)WithdrawnNCT03699384Phase 1/2
- High Dose Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM) in Patients Who Have Metastatic Pancreatic CancerWithdrawnNCT03697239Phase 1/2
- IMRT-TMI With Fludarabine as Myeloablative Conditioning for Allogeneic HSCTTerminatedNCT03696537Phase 1
- First Line Metastatic Pancreatic Cancer : 5FU/LV+Nal-IRI, Gemcitabine+Nab-paclitaxel or a Sequential Regimen of 2 Months 5FU/LV+Nal-IRICompletedNCT03693677Phase 2
- The Effect of Some Drugs Used in Treatment of Vasculitis on the Complement System in ChildrenStatus unknownNCT03692416Phase 3
- Compare Neoadjuvant DOS Combined With Toripalimab Versus SOX Combined With Toripalimab in Locally Advanced Gastric AdenocarcinomaActive, not recruitingNCT03691454Phase 2/3
- A Study of Pyrotinib Plus Capecitabine in Patients With Brain Metastases From HER2-positive Metastatic Breast CancerActive, not recruitingNCT03691051Phase 2
- Evaluation of Symptom Benefit Rate of Trabectedin/PLD in Patients With Recurrent Ovarian CancerTerminatedNCT03690739Phase 3
- PTCy-ATG vs ATG in Haploidentical HSCT for Acute Graft-versus-host Disease ProphylaxisStatus unknownNCT03689465Phase 4
- The Effect of Antioxidants on Skin Blood Flow During Local HeatingCompletedNCT03680638Phase 1
- The Effect of Antioxidants on Skin Blood Flow-BH4CompletedNCT03680573Phase 1
- The Effect of Local Antioxidant Therapy on Racial Differences in VasoconstrictionCompletedNCT03680404Phase 1
- A Prospective Randomized Trial of Capecitabine Treatment in Patients With HNSCCStatus unknownNCT03678649Phase 2
- Phase II/III of Randomized Controlled Clinical Research on IRE Synchronous Chemotherapy for LAPCCompletedNCT03673137Phase 2/3
- Neoadjuvant Chemotherapy With Gemcitabine Plus Cisplatin Followed by Radical Liver Resection Versus Immediate Radical Liver Resection Alone With or Without Adjuvant Chemotherapy in Incidentally Detected Gallbladder Carcinoma After Simple Cholecystectomy or in Front of Radical Resection of BTCCompletedNCT03673072Phase 3
- Liposome-encapsulated Daunorubicin-Cytarabine and Gemtuzumab Ozogamicin in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) or High Risk Myelodysplastic SyndromeCompletedNCT03672539Phase 2
- Non Squamous NSCLC Patients With Anlotinib Combined With Pemetrexed and CisplatinStatus unknownNCT03671538Not applicable
- S-1 Combined With IMRT Concurrent Chemoradiotherapy in Locally Advanced Nasopharyngeal CarcinomaCompletedNCT03668366Phase 2
- Treatment With Azacitidine of Recurrent Gliomas With IDH1/2 MutationActive, not recruitingNCT03666559Phase 2
- Low-dose Decitabine for the Treatment of Decreased Donor Chimerism After Allogeneic Stem Cell TransplantationCompletedNCT03663751Phase 2
- Dose Individualization of Pemetrexed - IMPROVE-IIICompletedNCT03655834Phase 4
- Dose Individualization of Pemetrexed - IMPROVE-IITerminatedNCT03655821Phase 4
- Phase I Nab-Paclitaxel Plus Gemcitabine With Proton Therapy for Locally Advanced Pancreatic Cancer (LAPC)Active, not recruitingNCT03652428Phase 1/2
- Efficacy and Safety of Low Dose Thalidomide in Transfusion Dependent ThalassemiaCompletedNCT03651102Phase 2/3
- Modified FOLFOX Plus/Minus Nivolumab and Ipilimumab vs. FLOT Plus Nivolumab in Patients With Previously Untreated Advanced or Metastatic Gastric CancerCompletedNCT03647969Phase 2
- Atezolizumab in Combination With Bevacizumab, Carboplatin and Pemetrexed for EGFR-mutant Metastatic NSCLC Patients After Failure of EGFR Tyrosine Kinase InhibitorsStatus unknownNCT03647956Phase 2
- Abraxane Combined With Xeloda as Neo-Adjuvant Chemotherapy in Early Breast CancerStatus unknownNCT03647514Not applicable
- Hydroxyurea and TransfusionCompletedNCT03644953Phase 2
- Olaparib + Sapacitabine in BRCA Mutant Breast CancerActive, not recruitingNCT03641755Phase 1
- Study of Anlotinib Combined With Gemcitabine/Cisplatin in Advanced Nasopharyngeal CarcinomaStatus unknownNCT03639467Phase 1/2
- Recurrence Score-guiding Chemotherapy in Non-pCR HR Positive HER2 Negative Breast Cancer After Neoadjuvant TherapyStatus unknownNCT03638648Phase 2
- Nivolumab or Nivolumab and Azacitidine in Patients With Recurrent, Resectable OsteosarcomaActive, not recruitingNCT03628209Phase 1
- Study of Pembrolizumab With Pemetrexed and Oxaliplatin in Chemo-Refractory Metastatic Colorectal Cancer PatientsStatus unknownNCT03626922Phase 1
- SIMPLE Chemotherapy for NK Lymphoma/LeukaemiaStatus unknownNCT03623087Phase 3
- Venetoclax Added to Fludarabine + Busulfan Prior to Transplant and to Maintenance Therapy for AML, MDS, and MDS/MPNActive, not recruitingNCT03613532Phase 1
- Acelarin First Line Randomised Pancreatic StudySuspendedNCT03610100Phase 2/3
- A Study of the Efficacy of Cannabidiol in Patients With Multiple Myeloma, Glioblastoma Multiforme, and GI MalignanciesStatus unknownNCT03607643Phase 1/2
- Pemetrexed in Maintenance in Patients With Impaired Renal Function, 2 Dose Calculation StrategiesCompletedNCT03607149Phase 4
- mFLOT Chemotherapy as First-line Treatment in GCCompletedNCT03606928Phase 1/2
- Chidamide Combined With Clad/Gem/Bu With AutoSCT in High Risk Hodgkin & Non-Hodgkin LymphomaStatus unknownNCT03602131Phase 2
- The Percentage of Cases of Acute Treatment With Allopurinol in Gout PatientsStatus unknownNCT03601260Not applicable
- Gemcitabine, Docetaxel, and Hydroxychloroquine in Treating Participants With Recurrent or Refractory OsteosarcomaActive, not recruitingNCT03598595Phase 1/2
- Evaluate the Efficacy of Maintenance Treatment With Capecitabine Plus Apatinib in Advanced Gastric CancerStatus unknownNCT03598348Phase 3
- Decitabine+BUCY vs BUCY Conditioning Regimen for MLL+ Acute Leukemia Undergoing Allo-HSCTStatus unknownNCT03596892Phase 2/3
- Efficacy and Safety of Oral Azacitidine Compared to Investigator's Choice Therapy in Patients With Relapsed or Refractory AITLCompletedNCT03593018Phase 3
- Herzuma-capecitabine/Cisplatin for Gastric CancerStatus unknownNCT03588533Phase 2
- Ixazomib, Gemcitabine, and Doxorubicin in Treating Patients With Locally Advanced or Metastatic Kidney CancerCompletedNCT03587662Phase 2
- A Combination of Vemurafenib, Cytarabine and 2-chlorodeoxyadenosine in Children With LCH and BRAF V600E MutationStatus unknownNCT03585686Phase 2
- Raltitrexed Concurrent With Radiotherapy for Elderly Chinese Patients With Squamous Cell Carcinoma of EsophagusStatus unknownNCT03585530Phase 2
- Nivolumab in Combination With Metronomic Chemotherapy in Paediatrics Refractory / Relapsing Solid TumorsTerminatedNCT03585465Phase 1/2
- CD19-Specific T Cells Post AlloSCTTerminatedNCT03579888Phase 1
- Chemotherapy Before & After Surgery in Patients With Resectable Gallbladder CancerWithdrawnNCT03579758Phase 3
- A Clinical Trial of Decitabine in Relapse and Refractory Diffuse Large B Cell LymphomaStatus unknownNCT03579082Phase 4
- Neoadjuvant Chemotherapy Followed by Preoperative Chemoradiation in Resectable Squamous-cell Esophageal CancerStatus unknownNCT03579004Phase 2
- SECOX as Neoadjuvant Therapy in Patients With Locally Advanced HCCCompletedNCT03578874Phase 2
- The Safety,Efficacy of Anti-EGFR Humanized Monoclonal Antibody Combined With Chemotherapy in Advanced Solid Tumors.CompletedNCT03577704Phase 1/2
- Treatment With Leflunomide in Patients With Polymyalgia RheumaticaStatus unknownNCT03576794Phase 3
- Phase II Umbrella Study Directed by Next Generation SequencingStatus unknownNCT03574402Phase 2
- CPX-351 (Vyxeos™) for Transplant Eligible, Higher Risk Patients With Myelodysplastic SyndromeActive, not recruitingNCT03572764Phase 1
- Infusion of 5-Azacytidine (5-AZA) Into the Fourth Ventricle in Patients With Recurrent Posterior Fossa EpendymomaCompletedNCT03572530Phase 1
- Neoadjuvant CCRT With Gemcitabine/Durvalumab (MEDI4736) Followed by Adjuvant Gemcitabine/Durvalumab(MEDI4736) in Resectable or Borderline Resectable Pancreatic CancerActive, not recruitingNCT03572400Phase 2
- A Trial Comparing Single Agent Melphalan to Carmustine, Etoposide, Cytarabine, and Melphalan (BEAM) as a Preparative Regimen for Patients With Multiple Myeloma Undergoing High Dose Therapy Followed by Autologous Stem Cell ReinfusionStatus unknownNCT03570983Phase 2
- Phase I Study of the Combination of Anlotinib With Pemetrexed or DocetaxelStatus unknownNCT03566576Not applicable
- Prospective Study on the Efficacy and Safety of 2 Week or 3 Week Xelox Regimen for Adjuvant Chemotherapy in CRCCompletedNCT03564912Phase 1/2